Product How it works Pricing Blog FAQ About Contact
Arcus Biosciences

Arcus Biosciences (NYSE: RCUS) revenue

Arcus Biosciences reported revenue of $247.0m for fiscal 2025, 4.3% less than in fiscal 2024 ($258.0m). Since fiscal 2017 its revenue has grown by 17,380.5%, an average growth of 90.7% a year.

Arcus Biosciences's best year of the last 9 was fiscal 2021. The biggest drop was in fiscal 2022, −70.8%.

Revenue, in millions of US dollars1.420178.4201815.0201978.02020383.02021112.02022117.02023258.02024247.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$247.0m−4.3%−$386.0m−156.3%
2024$258.0m+120.5%−$330.0m−127.9%
2023$117.0m+4.5%−$340.0m−290.6%
2022$112.0m−70.8%−$280.0m−250.0%
2021$383.0m+391.0%$54.0m14.1%
2020$78.0m+420.0%−$124.0m−159.0%
2019$15.0m+79.6%−$88.7m−591.4%
2018$8.4m+491.2%−$54.9m−656.8%
2017$1.4m—−$53.4m−3,782.1%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Arcus Biosciences revenue compared with its sector

By revenue for its latest fiscal year, Arcus Biosciences ranks 234th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Arcus Biosciences, −4.3%.

RankCompanyRevenueRevenue growth
232ndSchrodinger$255.9m23.3%
233rdLeMaitre Vascular$249.6m13.5%
234thArcus Biosciences$247.0m−4.3%
235thKeros Therapeutics$244.1m6,775.0%
236thSTAAR Surgical$239.4m−23.7%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Arcus Biosciences

How much revenue did Arcus Biosciences make in fiscal 2025?
Arcus Biosciences reported revenue of $247.0m for fiscal 2025, compared with $258.0m in fiscal 2024.
How much has the revenue of Arcus Biosciences grown?
Between fiscal 2017 and fiscal 2025 it went from $1.4m to $247.0m: 17,380.5% more, an average growth of 90.7% a year.
What was the best year for revenue at Arcus Biosciences?
Of its last 9 fiscal years, fiscal 2021, with $383.0m.
Where does Arcus Biosciences rank in its sector by revenue?
It ranks 234th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Arcus Biosciences come from?
From the annual report (Form 10-K) that Arcus Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Arcus Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Arcus Biosciences: the Arcus Biosciences page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.